Market Research Logo

Cell Viability Assays

Cell Viability Assays

Cell Viability Assays market worldwide is projected to grow by US$2 Billion, driven by a compounded growth of 8.1%. Consumables, one of the segments analyzed and sized in this study, displays the potential to grow at over 8.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$2.9 Billion by the year 2025, Consumables will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 9.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$87.9 Million to the region's size and clout in the next 5 to 6 years. Over US$91 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Consumables will reach a market size of US$223.1 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.7% over the next couple of years and add approximately US$333.7 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abcam PLC; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; BioTek Instruments, Inc.; Biotium, Inc.; Creative Bioarray; Danaher Corporation; GE Healthcare; Merck KgaA; PerkinElmer, Inc.; Promega Corporation; Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Cell Viability Assays Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Cell Viability Assays Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 2: Cell Viability Assays Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
TABLE 3: Cell Viability Assays Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
TABLE 4: Consumables (Product Type) World Market by Region/Country in US$ Million: 2018 to 2025
TABLE 5: Consumables (Product Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
TABLE 6: Consumables (Product Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 7: Instruments (Product Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
TABLE 8: Instruments (Product Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
TABLE 9: Instruments (Product Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
TABLE 10: Basic Research (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 11: Basic Research (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
TABLE 12: Basic Research (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 13: Stem Cell Research (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
TABLE 14: Stem Cell Research (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 15: Stem Cell Research (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
TABLE 16: Drug Discovery & Development (Application) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 17: Drug Discovery & Development (Application) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 18: Drug Discovery & Development (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 19: Clinical & Diagnostic Applications (Application) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2018 through 2025
TABLE 20: Clinical & Diagnostic Applications (Application) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2009 to 2017
TABLE 21: Clinical & Diagnostic Applications (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025
TABLE 22: Other Applications (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
TABLE 23: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 24: Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
TABLE 25: Academic & Research Institutes (End-Use) Worldwide Sales in US$ Million by Region/Country: 2018-2025
TABLE 26: Academic & Research Institutes (End-Use) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
TABLE 27: Academic & Research Institutes (End-Use) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
TABLE 28: Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 29: Pharmaceutical & Biotechnology Companies (End-Use) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
TABLE 30: Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
TABLE 31: Hospital & Diagnostic Laboratories (End-Use) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
TABLE 32: Hospital & Diagnostic Laboratories (End-Use) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
TABLE 33: Hospital & Diagnostic Laboratories (End-Use) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025
TABLE 34: Other End-Uses (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2018-2025
TABLE 35: Other End-Uses (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2009-2017
TABLE 36: Other End-Uses (End-Use) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Cell Viability Assays Market Share (in %) by Company: 2019 & 2025
TABLE 37: United States Cell Viability Assays Market Estimates and Projections in US$ Million by Product Type: 2018 to 2025
TABLE 38: Cell Viability Assays Market in the United States by Product Type: A Historic Review in US$ Million for 2009-2017
TABLE 39: United States Cell Viability Assays Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
TABLE 40: United States Cell Viability Assays Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
TABLE 41: Cell Viability Assays Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
TABLE 42: Cell Viability Assays Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
TABLE 43: United States Cell Viability Assays Latent Demand Forecasts in US$ Million by End-Use: 2018 to 2025
TABLE 44: Cell Viability Assays Historic Demand Patterns in the United States by End-Use in US$ Million for 2009-2017
TABLE 45: Cell Viability Assays Market Share Breakdown in the United States by End-Use: 2009 VS 2019 VS 2025
CANADA
TABLE 46: Canadian Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025
TABLE 47: Canadian Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2009-2017
TABLE 48: Cell Viability Assays Market in Canada: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025
TABLE 49: Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 50: Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 51: Canadian Cell Viability Assays Market Share Analysis by Application: 2009 VS 2019 VS 2025
TABLE 52: Canadian Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 53: Cell Viability Assays Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 54: Canadian Cell Viability Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
JAPAN
TABLE 55: Japanese Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025
TABLE 56: Cell Viability Assays Market in Japan: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017
TABLE 57: Japanese Cell Viability Assays Market Share Analysis by Product Type: 2009 VS 2019 VS 2025
TABLE 58: Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2018 to 2025
TABLE 59: Japanese Cell Viability Assays Market in US$ Million by Application: 2009-2017
TABLE 60: Cell Viability Assays Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
TABLE 61: Japanese Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2018 to 2025
TABLE 62: Japanese Cell Viability Assays Market in US$ Million by End-Use: 2009-2017
TABLE 63: Cell Viability Assays Market Share Shift in Japan by End-Use: 2009 VS 2019 VS 2025
CHINA
TABLE 64: Chinese Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025
TABLE 65: Cell Viability Assays Historic Market Analysis in China in US$ Million by Product Type: 2009-2017
TABLE 66: Chinese Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 67: Chinese Demand for Cell Viability Assays in US$ Million by Application: 2018 to 2025
TABLE 68: Cell Viability Assays Market Review in China in US$ Million by Application: 2009-2017
TABLE 69: Chinese Cell Viability Assays Market Share Breakdown by Application: 2009 VS 2019 VS 2025
TABLE 70: Chinese Demand for Cell Viability Assays in US$ Million by End-Use: 2018 to 2025
TABLE 71: Cell Viability Assays Market Review in China in US$ Million by End-Use: 2009-2017
TABLE 72: Chinese Cell Viability Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
EUROPE
Market Facts & Figures
European Cell Viability Assays Market: Competitor Market Share Scenario (in %) for 2019 & 2025
TABLE 73: European Cell Viability Assays Market Demand Scenario in US$ Million by Region/Country: 2018-2025
TABLE 74: Cell Viability Assays Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
TABLE 75: European Cell Viability Assays Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
TABLE 76: European Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025
TABLE 77: Cell Viability Assays Market in Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017
TABLE 78: European Cell Viability Assays Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
TABLE 79: European Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 80: Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 81: European Cell Viability Assays Market Share Analysis by Application: 2009 VS 2019 VS 2025
TABLE 82: European Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 83: Cell Viability Assays Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 84: European Cell Viability Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
FRANCE
TABLE 85: Cell Viability Assays Market in France by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 86: French Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2009-2017
TABLE 87: French Cell Viability Assays Market Share Analysis by Product Type: 2009 VS 2019 VS 2025
TABLE 88: Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
TABLE 89: French Cell Viability Assays Historic Market Review in US$ Million by Application: 2009-2017
TABLE 90: French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
TABLE 91: Cell Viability Assays Quantitative Demand Analysis in France in US$ Million by End-Use: 2018-2025
TABLE 92: French Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 93: French Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
GERMANY
TABLE 94: Cell Viability Assays Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product Type for the Period 2018-2025
TABLE 95: German Cell Viability Assays Historic Market Analysis in US$ Million by Product Type: 2009-2017
TABLE 96: German Cell Viability Assays Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
TABLE 97: Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
TABLE 98: German Cell Viability Assays Market in Retrospect in US$ Million by Application: 2009-2017
TABLE 99: Cell Viability Assays Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
TABLE 100: Cell Viability Assays Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2018-2025
TABLE 101: German Cell Viability Assays Market in Retrospect in US$ Million by End-Use: 2009-2017
TABLE 102: Cell Viability Assays Market Share Distribution in Germany by End-Use: 2009 VS 2019 VS 2025
ITALY
TABLE 103: Italian Cell Viability Assays Market Growth Prospects in US$ Million by Product Type for the Period 2018-2025
TABLE 104: Cell Viability Assays Historic Market Analysis in Italy in US$ Million by Product Type: 2009-2017
TABLE 105: Italian Cell Viability Assays Market by Product Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
TABLE 106: Italian Demand for Cell Viability Assays in US$ Million by Application: 2018 to 2025
TABLE 107: Cell Viability Assays Market Review in Italy in US$ Million by Application: 2009-2017
TABLE 108: Italian Cell Viability Assays Market Share Breakdown by Application: 2009 VS 2019 VS 2025
TABLE 109: Italian Demand for Cell Viability Assays in US$ Million by End-Use: 2018 to 2025
TABLE 110: Cell Viability Assays Market Review in Italy in US$ Million by End-Use: 2009-2017
TABLE 111: Italian Cell Viability Assays Market Share Breakdown by End-Use: 2009 VS 2019 VS 2025
UNITED KINGDOM
TABLE 112: United Kingdom Market for Cell Viability Assays: Annual Sales Estimates and Projections in US$ Million by Product Type for the Period 2018-2025
TABLE 113: Cell Viability Assays Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product Type for the Period 2009-2017
TABLE 114: United Kingdom Cell Viability Assays Market Share Analysis by Product Type: 2009 VS 2019 VS 2025
TABLE 115: United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by Application: 2018 to 2025
TABLE 116: United Kingdom Cell Viability Assays Market in US$ Million by Application: 2009-2017
TABLE 117: Cell Viability Assays Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
TABLE 118: United Kingdom Demand Estimates and Forecasts for Cell Viability Assays in US$ Million by End-Use: 2018 to 2025
TABLE 119: United Kingdom Cell Viability Assays Market in US$ Million by End-Use: 2009-2017
TABLE 120: Cell Viability Assays Market Share Shift in the United Kingdom by End-Use: 2009 VS 2019 VS 2025
REST OF EUROPE
TABLE 121: Rest of Europe Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2018-2025
TABLE 122: Cell Viability Assays Market in Rest of Europe in US$ Million by Product Type: A Historic Review for the Period 2009-2017
TABLE 123: Rest of Europe Cell Viability Assays Market Share Breakdown by Product Type: 2009 VS 2019 VS 2025
TABLE 124: Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by Application: 2018-2025
TABLE 125: Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
TABLE 126: Rest of Europe Cell Viability Assays Market Share Analysis by Application: 2009 VS 2019 VS 2025
TABLE 127: Rest of Europe Cell Viability Assays Addressable Market Opportunity in US$ Million by End-Use: 2018-2025
TABLE 128: Cell Viability Assays Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2009-2017
TABLE 129: Rest of Europe Cell Viability Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
ASIA-PACIFIC
TABLE 130: Cell Viability Assays Market in Asia-Pacific by Product Type: Estimates and Projections in US$ Million for the Period 2018-2025
TABLE 131: Asia-Pacific Cell Viability Assays Historic Market Scenario in US$ Million by Product Type: 2009-2017
TABLE 132: Asia-Pacific Cell Viability Assays Market Share Analysis by Product Type: 2009 VS 2019 VS 2025
TABLE 133: Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
TABLE 134: Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by Application: 2009-2017
TABLE 135: Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
TABLE 136: Cell Viability Assays Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2018-2025
TABLE 137: Asia-Pacific Cell Viability Assays Historic Market Review in US$ Million by End-Use: 2009-2017
TABLE 138: Asia-Pacific Cell Viability Assays Market Share Analysis: A 17-Year Perspective by End-Use for 2009, 2019, and 2025
REST OF WORLD
TABLE 139: Rest of World Cell Viability Assays Market Estimates and Forecasts in US$ Million by Product Type: 2018 to 2025
TABLE 140: Rest of World Cell Viability Assays Historic Market Review by Product Type in US$ Million: 2009-2017
TABLE 141: Cell Viability Assays Market in Rest of World: Percentage Share Breakdown of Sales by Product Type for 2009, 2019, and 2025
TABLE 142: Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
TABLE 143: Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
TABLE 144: Rest of World Cell Viability Assays Market Share Analysis by Application: 2009 VS 2019 VS 2025
TABLE 145: Rest of World Cell Viability Assays Market Quantitative Demand Analysis in US$ Million by End-Use: 2018 to 2025
TABLE 146: Cell Viability Assays Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2009-2017
TABLE 147: Rest of World Cell Viability Assays Market Share Analysis by End-Use: 2009 VS 2019 VS 2025
IV. COMPETITION
ABCAM PLC
BIO-RAD LABORATORIES
BIO-TEK INSTRUMENTS
BIOTIUM, INC.
CREATIVE BIOARRAY
DANAHER CORPORATION
MERCK KGAA
PERKINELMER
PROMEGA CORPORATION
THERMO FISHER SCIENTIFIC
V. CURATED RESEARCH

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook